@article{Martin:100717,
author = "Martin, M. and Zielinski, C. and Ruiz-Borrego, M. and
Carrasco, E. and Turner, N. and Ciruelos, E.M. and Muñoz,
M. and Bermejo, B. and Margeli, M. and Anton, A. and Kahan,
Z. and Csöszi, T. and Casas, M.I. and Murillo, L. and
Morales, S. and Alba, E. and Gal-Yam, E. and
Guerrero-Zotano, A. and Calvo, L. and de la Haba-Rodriguez,
J. and Ramos, M. and Alvarez, I. and Garcia-Palomo, A. and
Huang Bartlett, C. and Koehler, M. and Caballero, R. and
Corsaro, M. and Huang, X. and Garcia-Sáenz, J.A. and
Chacón, J.I. and Swift, C. and Thallinger, C. and Gil-Gil,
M.",
title = "{Palbociclib in combination with endocrine therapy versus
capecitabine in hormonal receptor-positive, human epidermal
growth factor 2-negative, aromatase inhibitor-resistant
metastatic breast cancer: a phase III randomised controlled
trial—PEARL}",
year = "2021",
}